XM, Amerika Birleşik Devletleri'nde ikamet edenlere hizmet sunmamaktadır.
C
C

Cognizant


Haberler

Oracle shares pare gains as analysts weigh over $100 billion fiscal 2029 revenue forecast

UPDATE 1-Oracle shares pare gains as analysts weigh over $100 billion fiscal 2029 revenue forecast Shares rise 1.9% Oracle forecasts FY29 revenue to be $104 billion Raises fiscal 2026 revenue outlook Adds analyst comment in paragraphs 3 and 4, updates shares By Jaspreet Singh Sept 13 (Reuters) - Oracle ORCL.N shares pared most of their gains on Friday after spiking nearly 8%, with some analysts expressing reservations about the company's forecast of crossing $100 billion in revenue in fiscal 202
A
A
C
M
L

Oracle shares rise as it expects to cross $100 billion in fiscal 2029 sales

Oracle shares rise as it expects to cross $100 billion in fiscal 2029 sales Shares rise more than 6% in premarket trading Oracle forecasts FY29 revenue to be $104 billion Raises fiscal 2026 revenue outlook Sept 13 (Reuters) - Oracle ORCL.N shares rose more than 6% in premarket trading on Friday after the company said it expects to cross $100 billion in revenue in fiscal 2029, as the popularity of AI drives demand for its cloud services.
A
A
C
M
L

U.S. Constellation Energy, Eli Lilly, Talen Energy

U.S. RESEARCH ROUNDUP-Constellation Energy, Eli Lilly, Talen Energy Sept 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Constellation Energy, Eli Lilly and Talen Energy, on Friday. HIGHLIGHTS * Constellation Energy Corp CEG.O : Jefferies initiates with hold rating; target $183 * Eli Lilly LLY.N : JP Morgan raises target price to $1,100 from $1,050 * Moderna MRNA.O : JP Morgan cuts to underweight from neutral * Vo
A
C
C
F
F
H
H
H
I
K
W
F
D
T
Z
A
A
D
E
H
L

U.S. Broadcom, Costco Wholesale, Saia

U.S. RESEARCH ROUNDUP-Broadcom, Costco Wholesale, Saia Sept 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Broadcom, Costco Wholesale and Saia on Friday. HIGHLIGHTS * Broadcom Inc AVGO.O : JP Morgan raises target price to $210 from $200 * Costco Wholesale Corp COST.O : Oppenheimer raises target price to $955 from $925 * Globant SA GLOB.N : JP Morgan raises target price to $237 from $226 * Saia Inc SAIA.O : JP Morg
A
B
C
C
E
D
M
Z
C
F
I
R

Gen AI boosting productivity of Indian IT industry's fastest-growing niche, TCS exec says

Gen AI boosting productivity of Indian IT industry's fastest-growing niche, TCS exec says By Sai Ishwarbharath B BENGALURU, Sept 5 (Reuters) - Generative AI is helping India's top IT firm Tata Consultancy Services TCS.NS accelerate development in the industry's fastest-growing niche of engineering research and design, a senior executive told Reuters.
C
I
S
R

Golf-Weir adds Canadian flavour to Presidents Cup, U.S. leave out Thomas

UPDATE 1-Golf-Weir adds Canadian flavour to Presidents Cup, U.S. leave out Thomas Adds details in paragraphs 1-2 and 7-10 Sept 3 (Reuters) - Mike Weir named fellow Canadians Corey Conners, Taylor Pendrith and Mackenzie Hughes to his International Team for this month's Presidents Cup on home soil while matchplay specialist Justin Thomas was notably left off the U.S.
C

Golf-Weir adds three Canadians to Presidents Cup squad

Golf-Weir adds three Canadians to Presidents Cup squad Sept 3 (Reuters) - International Team captain Mike Weir on Tuesday named fellow Canadians Corey Conners, Taylor Pendrith and Mackenzie Hughes to his squad for this month's Presidents Cup on home soil at Royal Montreal. The Canadian trio were added as captain's picks along with South Africa's Christiaan Bezuidenhout, South Korea's Kim Si-woo and Australia's Min Woo Lee to the 12-player team that will face a powerhouse U.S.
C

U.S. Alamo Group, Cognizant, Moderna

U.S. RESEARCH ROUNDUP-Alamo Group, Cognizant, Moderna Aug 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alamo Group, Cognizant and Moderna, on Wednesday. HIGHLIGHTS * Alamo Group Inc ALG.N : D.A. Davidson raises target price to $219 from $209 * Cognizant CTSH.O : Jefferies reinstates coverage with buy rating; price target $90 * Moderna MRNA.O : HSBC raises to hold from reduce * Sonic Automotive SAH.N : CFRA rais
C
C
C
E

U.S. Alamo Group, Cognizant, Moderna

CORRECTED-U.S. RESEARCH ROUNDUP- Alamo Group, Cognizant, Moderna Corrects ESS Tech Inc entry to say Deutsche Bank adjusts PT to $9 from $0.90 to reflect 1-for-15 reverse stock split Aug 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alamo Group, Cognizant and Moderna, on Wednesday.
C
G
M
S
U
C
E
P

Cognizant Outlook FY Adjusted EPS USD 4.56-4.64

BRIEF-Cognizant Outlook FY Adjusted EPS USD 4.56-4.64 Aug 27 (Reuters) - Cognizant outlook FY revenue USD 19,500-19,800 million.
C

U.S. Antero Resources, Coterra Energy, Netflix

U.S. RESEARCH ROUNDUP- Antero Resources, Coterra Energy, Netflix Aug 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Antero Resources, Coterra Energy and Netflix on Tuesday. HIGHLIGHTS * Aadi Bioscience Inc AADI.O : Piper Sandler cuts to neutral from overweight * Antero Resources Corp AR.N : Roth MKM initiates coverage with buy rating; PT $32 * Coterra Energy Inc CTRA.N : Roth MKM raises to buy * Energizer Holding
C
N
N
E
T

Cognizant sues software rival Infosys over trade secrets

UPDATE 1-Cognizant sues software rival Infosys over trade secrets Adds Infosys response in paragraph 3 By Blake Brittain Aug 23 (Reuters) - Software provider Cognizant TriZetto AXPAST.UL sued Indian tech company Infosys INFY.NS in Texas federal court on Friday, accusing Infosys of stealing trade secrets related to its healthcare insurance software.
A
C
I

Cognizant sues software rival Infosys over trade secrets

Cognizant sues software rival Infosys over trade secrets By Blake Brittain Aug 23 (Reuters) - Software provider Cognizant TriZetto AXPAST.UL sued Indian tech company Infosys INFY.NS in Texas federal court on Friday, accusing Infosys of stealing trade secrets related to its healthcare insurance software. Cognizant said in the lawsuit that Infosys unlawfully extracted data from its databases and used it to build and market competing software.
A
C
I

Software provider EPAM beat quarterly results on strong AI adoption

Software provider EPAM beat quarterly results on strong AI adoption Aug 8 (Reuters) - EPAM Systems EPAM.N beat quarterly profit and revenue estimates on Thursday, helped by strong demand for its IT services as businesses are increasingly digitizing their operations. The positive result underscores the recovery of demand for IT services as clients are increasingly adopting cloud services and look to deploy their own AI applications, helping companies that provide product development services such
C

Nasdaq top and bottom performing stocks at about 12:01 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 12:01 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Meta Platforms Inc META.OQ +6.1% Dexcom Inc DXCM.OQ +3.5% Cognizant Technology Solutions Corp CTSH.OQ +2.8% Vertex Pharmaceuticals Inc VRTX.OQ +1.8% AstraZeneca PLC AZN.OQ +1.4% Bottom Performers Percent Change Moderna Inc MRNA.OQ -19.5% Arm Holdings PLC ARM.OQ -16.0% Qualcomm Inc QCOM.OQ -8.7% Lam Research Corp LRCX.OQ -8.3% Micron Technology Inc MU.OQ -6.7% The Nasdaq 100 .NDX l
A
C
M
Q
V
L
U
D

U.S. CH Robinson Worldwide, Dayforce, Entegris

U.S. RESEARCH ROUNDUP-CH Robinson Worldwide, Dayforce, Entegris Aug 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CH Robinson Worldwide, Dayforce and Entegris, on Thursday. HIGHLIGHTS * CH Robinson Worldwide Inc CHRW.O : JP Morgan raises to overweight from neutral * Dayforce Inc DAY.N : Piper Sandler raises to overweight from neutral * Entegris Inc ENTG.O : Seaport Research Partners raises to buy from neutral * M
B
C
D
E
M
Q
S
V
A
C
D
E
L
T
P
W
A
B
C

Cognizant raises full year revenue forecast, beats Q2 results estimates

Cognizant raises full year revenue forecast, beats Q2 results estimates July 31 (Reuters) - Cognizant Technology Solutions CTSH.O raised its annual revenue forecast and and beat second-quarter results estimates on Wednesday, aided by businesses turning to the IT services provider to digitize their operations. Signs of easing inflation and expectations of lower interest rates are prompting businesses to increase their spending on technology and consulting projects as they transition to cloud-base
C
I

Cognizant Q2 Adjusted EPS USD 1.17 Vs. IBES Estimate USD 1.12

BRIEF-Cognizant Q2 Adjusted EPS USD 1.17 Vs. IBES Estimate USD 1.12 Jul 31 (Reuters) - Cognizant Q2 operating income USD 708 million. Q2 adjusted operating margin 15.2% Q2 EPS USD 1.14 Q2 revenue USD 4,850 million vs. IBES estimate USD 4,802 million Q2 operating margin 14.6% outlook Q3 revenue USD 4,890-4,960 million outlook FY adjusted EPS USD 4.6
C

BOJ hikes with Fed ahead, Big Tech flubs

MORNING BID AMERICAS-BOJ hikes with Fed ahead, Big Tech flubs A look at the day ahead in U.S. and global markets from Mike Dolan By any standards of an already busy year, markets are digesting an awful lot of information in a very short space of time - with a Bank of Japan interest rate rise and Microsoft earnings disappointment the latest servings on the final day of July.
B
C
E
G
G
H
M
M
N
Q
U
V
W
K
L
G
J
U
U
U
F
I
P
B
E

U.S. Colgate-Palmolive, McKesson, Microsoft

U.S. RESEARCH ROUNDUP-Colgate-Palmolive, McKesson, Microsoft July 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Colgate-Palmolive, McKesson and Microsoft, on Tuesday. HIGHLIGHTS * Colgate-Palmolive Co CL.N : TD Cowen initiates coverage with buy rating; PT $110 * DR Horton Inc DHI.N : JP Morgan raises target price to $180 from $163 * IQVIA Holdings Inc IQV.N : Baird raises target price to $251 from $235 * McKesso
C
H
M
M
T
V
Z
F
A
M
A
C
C
D
I



Şartlar

Popüler varlıklar

Bildirim: XM Group şirketlerinin her biri yalnızca gerçekleştirme hizmeti ve online yatırım platformumuza erişim sağlar. Herhangi bir kişinin web sitesinde bulunan veya web sitesi üzerinden sağlanan içeriği görüntülemesine ve/veya kullanmasına izin vermek, bu hizmeti değiştirmek veya genişletmek amaçlı değildir ve bu hizmeti ne değiştirir ne de genişletir. Bu tür erişim ve kullanım her zaman şunlara tabidir: (i) Şartlar ve Koşullar; (ii) Risk Uyarıları ve (iii) Tam Bildirim. Bu nedenle bu tür içerikler yalnızca genel bilgi amacıyla sağlanır. Özellikle, online yatırım platformumuzun içeriklerinin finans piyasalarında herhangi bir işleme girmek için bir teşvik veya bir teklif olmadığını lütfen dikkate alın. Herhangi bir finans piyasasında yatırım yapmak sermayeniz için önemli düzeyde risk taşır.

Online yatırım platformumuzda yayınlanan tüm materyaller yalnızca eğitim/bilgilendirme amaçlıdır ve finansal tavsiye, yatırım vergisi veya yatırım tavsiyesi ve önerileri ya da yatırım fiyatlarımızın kaydı veya herhangi bir finansal enstrümanda işlem yapılması için bir teklif veya teşvik ya da talep edilmemiş finansal promosyonları içermez ve içerdiği şeklinde bir değerlendirme yapılmamalıdır.

Görüşler, haberler, araştırma, analizler, fiyatlar, diğer bilgiler veya bu web sitesinde bulunan üçüncü taraf sitelere verilen bağlantılar gibi her türlü üçüncü taraf içeriğin yanı sıra XM tarafından hazırlanan içerik de “olduğu gibi” esasına göre, genel piyasa yorumu olarak sağlanır ve bir yatırım tavsiyesi oluşturmaz. Herhangi bir içeriğin yatırım araştırması olarak yorumlanmasıyla ilgili olarak, içeriğin bağımsız yatırım araştırmasını desteklemek üzere tasarlanmış yasal gerekliliklere uygun hazırlanmadığını ve bu amacın güdülmediğini, aynı şekilde ilgili yasalar ve mevzuatlar kapsamında pazarlama iletişimi olarak değerlendirileceğini dikkate almalı ve kabul etmelisiniz. Buradan erişebileceğiniz Bağımsız Olmayan Yatırım Araştırması Bildirimimizi ve yukarıdaki bilgilerle ilgili Risk Uyarımızı okuduğunuzdan ve anladığınızdan emin olun.

Risk uyarısı: Sermayeniz risk altında. Kaldıraçlı ürünler herkese uygun olmayabilir. Lütfen Risk Bildirimi'mizi dikkate alın.